89 related articles for article (PubMed ID: 21412722)
1. Rodent models of amyotrophic lateral sclerosis.
McGoldrick P; Joyce PI; Fisher EM; Greensmith L
Biochim Biophys Acta; 2013 Sep; 1832(9):1421-36. PubMed ID: 23524377
[TBL] [Abstract][Full Text] [Related]
2. Current view and perspectives in amyotrophic lateral sclerosis.
Mathis S; Couratier P; Julian A; Corcia P; Le Masson G
Neural Regen Res; 2017 Feb; 12(2):181-184. PubMed ID: 28400790
[TBL] [Abstract][Full Text] [Related]
3. Molecular hallmarks of ageing in amyotrophic lateral sclerosis.
Jagaraj CJ; Shadfar S; Kashani SA; Saravanabavan S; Farzana F; Atkin JD
Cell Mol Life Sci; 2024 Mar; 81(1):111. PubMed ID: 38430277
[TBL] [Abstract][Full Text] [Related]
4. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia.
Walker C; El-Khamisy SF
Brain; 2018 May; 141(5):1247-1262. PubMed ID: 29584802
[TBL] [Abstract][Full Text] [Related]
5. Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice.
Anzilotti S; Valente V; Brancaccio P; Franco C; Casamassa A; Lombardi G; Palazzi A; Conte A; Paladino S; Canzoniero LMT; Annunziato L; Pierantoni GM; Pignataro G
Biomed Pharmacother; 2023 Nov; 167():115503. PubMed ID: 37729728
[TBL] [Abstract][Full Text] [Related]
6. Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis.
Zhou W; Xu R
Front Neurosci; 2023; 17():1189470. PubMed ID: 37638324
[TBL] [Abstract][Full Text] [Related]
7. Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival.
Waller R; Bury JJ; Appleby-Mallinder C; Wyles M; Loxley G; Babel A; Shekari S; Kazoka M; Wollff H; Al-Chalabi A; Heath PR; Shaw PJ; Kirby J
Brain Commun; 2024; 6(1):fcad331. PubMed ID: 38162899
[TBL] [Abstract][Full Text] [Related]
8. Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.
Paratore S; Pezzino S; Cavallaro S
Curr Genomics; 2012 Jun; 13(4):321-33. PubMed ID: 23204922
[TBL] [Abstract][Full Text] [Related]
9. Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects.
Lin TJ; Cheng GC; Wu LY; Lai WY; Ling TY; Kuo YC; Huang YH
Front Cell Dev Biol; 2022; 10():851613. PubMed ID: 35372346
[TBL] [Abstract][Full Text] [Related]
10. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.
Nayab DE; Din FU; Ali H; Kausar WA; Urooj S; Zafar M; Khan I; Shabbir K; Khan GM
J Nanobiotechnology; 2023 Dec; 21(1):477. PubMed ID: 38087359
[TBL] [Abstract][Full Text] [Related]
11. Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.
Nabavi SM; Arab L; Jarooghi N; Bolurieh T; Abbasi F; Mardpour S; Azimyian V; Moeininia F; Maroufizadeh S; Sanjari L; Hosseini SE; Aghdami N
Cell J; 2019 Jan; 20(4):592-598. PubMed ID: 30124008
[TBL] [Abstract][Full Text] [Related]
12. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.
Morello G; Spampinato AG; Conforti FL; D'Agata V; Cavallaro S
J Mol Neurosci; 2017 Apr; 61(4):563-580. PubMed ID: 28236105
[TBL] [Abstract][Full Text] [Related]
13. Boundary Cap Neural Crest Stem Cells Promote Survival of Mutant SOD1 Motor Neurons.
Aggarwal T; Hoeber J; Ivert P; Vasylovska S; Kozlova EN
Neurotherapeutics; 2017 Jul; 14(3):773-783. PubMed ID: 28070746
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients.
LoGerfo A; Chico L; Borgia L; Petrozzi L; Rocchi A; D'Amelio A; Carlesi C; Caldarazzo Ienco E; Mancuso M; Siciliano G
Oxid Med Cell Longev; 2014; 2014():432626. PubMed ID: 24672634
[TBL] [Abstract][Full Text] [Related]
15. Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Bai L; Hecker J; Kerstetter A; Miller RH
Neurosci Bull; 2013 Apr; 29(2):239-50. PubMed ID: 23471865
[TBL] [Abstract][Full Text] [Related]
16. Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
Carlesi C; Pasquali L; Piazza S; Lo Gerfo A; Caldarazzo Ienco E; Alessi R; Fornai F; Siciliano G
Arch Ital Biol; 2011 Mar; 149(1):151-67. PubMed ID: 21412722
[TBL] [Abstract][Full Text] [Related]
17. Excitotoxicity and amyotrophic lateral sclerosis.
Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
[TBL] [Abstract][Full Text] [Related]
18. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
Van den Bosch L
Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
[TBL] [Abstract][Full Text] [Related]
19. Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis.
Phukan J
IDrugs; 2010 Jul; 13(7):482-96. PubMed ID: 20582873
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
